Syverson Strege & Co’s Idexx Laboratories IDXX Stock Holding History

Syverson Strege & Co’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13	Closed	-$8K	–	382
2021 Q3	$8K	Buy	+13	New	+$8.73K	0.01%	265

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Syverson Strege & Co's IDXX Position: Q4 2021 in Review

Syverson Strege & Co sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 13 shares — an estimated $8K sold.

Syverson Strege & Co first reported a position in IDXX in Q3 2021 and held it in 1 quarter. The position peaked at $8K in Q3 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

Syverson Strege & Co reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
Syverson Strege & Co sold 13 Idexx Laboratories shares in Q4 2021, an estimated $8K.
Syverson Strege & Co first reported a position in Idexx Laboratories in Q3 2021 and held it in 1 quarter.
Syverson Strege & Co's Idexx Laboratories position peaked at $8K in Q3 2021.
1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Syverson Strege & Co's 13F filing for Q4 2021, filed 19 Jan 2022.